How should healthcare providers approach GLP-1 Agonists (Ozempic, Wegovy, etc.)?
Update: 2024-07-18
Description
After the boom in usage of weight loss inhibitors last year by the likes of Ozempic, Wegovy, Mounjaro and more, it's time to take a step back and look at how these new medications have changed our healthcare landscape.
Personal Trainer Brendan Copley, CSCS, ATC, and Nutritionist Ashley Jerry, MS, tackle the important questions of who should be taking these GLP-1 Agonist medications, concerns to watch out for, what to think about when coming and off the medication, and finally, what other healthy habits should be incorporated into the process to ensure clients stay healthy and achieve the results they were looking for.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
